Rate My Professor Ryan Duchatel
Ratings & reviews
Brings real-world insights to the classroom.
Knowledgeable and truly inspiring educator.
Makes complex ideas simple and clear.
Great Professor!
Taught by or worked with Ryan?
Add your rating. It takes about 30 seconds.
About Ryan
Dr. Ryan Duchatel is a Cancer Institute NSW Fellow and postdoctoral researcher in the School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, at the University of Newcastle, Australia. He earned his PhD in Experimental Pharmacology from the University of Newcastle in 2018, following Bachelor degrees in Biomedical Sciences with Honours from the same institution. As a member of the Cancer Signalling Research Group led by Dr. Matthew Dun at the Hunter Medical Research Institute, Duchatel specializes in pediatric high-grade gliomas, particularly diffuse intrinsic pontine glioma (DIPG). His research encompasses in vitro neurosphere modeling, high-resolution quantitative proteomics, identification of compensatory signaling pathways, and development of novel therapeutic strategies targeting PI3K/mTOR dependencies, mitochondrial protease ClpP, and combination therapies like ONC201 with paxalisib.
Duchatel's contributions are recognized through awards such as the Cancer Institute NSW Career Development Fellowship (2025–2028) and the ChadTough Defeat DIPG Fellowship (2023–2025). He holds key roles including Deputy Chair of the Hunter Cancer Research Alliance Future Leaders Group and serves on the scientific advisory committee of the Hunter Cancer Biobank. Notable publications include "PI3K/mTOR is a therapeutically targetable genetic dependency in diffuse intrinsic pontine glioma" (Journal of Clinical Investigation, 2024), "ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma" (Cancer Research, 2023), "Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies" (Oncogene, 2022), "Blockade of ROS production inhibits oncogenic signaling in acute myeloid leukemia and amplifies response to precision therapies" (Science Signaling, 2023), and "Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways" (Cancer Discovery, 2023). These works underscore his impact on advancing precision medicine for aggressive pediatric cancers.
Trending Biology Research & Publication News
AI Research Scooping: OpenAI & Anthropic Priority Disputes
Photo by Brecht Corbeel on Unsplash
Image Manipulation Detection Adoption Rising | AcademicJobs
Photo by Michael Shtern on Unsplash
AI Tools Flag Doctored Research Data | AcademicJobs
Photo by Emanuel Saleniuc on Unsplash
Molecular Structure Prediction Models in the Lab
Photo by ThisisEngineering on Unsplash
Beach Science: 7 Things to Teach Kids | AcademicJobs
Photo by Caroline Pasarin on Unsplash
Aquiline Nose: Genes That Control Nose Shape
Photo by Velizar Ivanov on Unsplash
Autophagy: What Research Reveals About Detox | AcademicJobs
Photo by Markus Winkler on Unsplash